Abstract
Safety and Preliminary Efficacy in Patients with Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel in Transcend NHL 001
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have